关注
peter carroll
peter carroll
在 ucsf.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
44912018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
26592018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
25052018
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
N Weidner, PR Carroll, J Flax, W Blumenfeld, J Folkman
The American journal of pathology 143 (2), 401, 1993
23871993
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
22002018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
20562018
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, GR Cunha, P Hein, ...
Breast Cancer Research 2, 1-1, 2000
20042000
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
16162018
Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy
V Ficarra, G Novara, RC Rosen, W Artibani, PR Carroll, A Costello, ...
European urology 62 (3), 405-417, 2012
12952012
Time trends and local variation in primary treatment of localized prostate cancer
MR Cooperberg, JM Broering, PR Carroll
Journal of Clinical Oncology 28 (7), 1117, 2010
11362010
Overdiagnosis and overtreatment of prostate cancer
S Loeb, MA Bjurlin, J Nicholson, TL Tammela, DF Penson, HB Carter, ...
European urology 65 (6), 1046-1055, 2014
10382014
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
9242018
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
8842018
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
J Kurhanewicz, DB Vigneron, H Hricak, P Narayan, P Carroll, SJ Nelson
Radiology 198 (3), 795-805, 1996
8771996
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images
J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
8442018
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
8392018
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after …
MR Cooperberg, DJ Pasta, EP Elkin, MS Litwin, DM Latini, J Du Chane, ...
The Journal of urology 173 (6), 1938-1942, 2005
8352005
Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study
J Scheidler, H Hricak, DB Vigneron, KK Yu, DL Sokolov, LR Huang, ...
Radiology 213 (2), 473-480, 1999
7941999
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
EA Klein, MR Cooperberg, C Magi-Galluzzi, JP Simko, SM Falzarano, ...
European urology 66 (3), 550-560, 2014
7362014
Comprehensive analysis of alternative splicing across tumors from 8,705 patients
A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ...
Cancer cell 34 (2), 211-224. e6, 2018
7252018
系统目前无法执行此操作,请稍后再试。
文章 1–20